NTRK1 and melanoma: IGF1R (insulin-like growth factor I receptor), another receptor tyrosine kinases found to be upregulated in our sample, has been found to have anti-apoptotic properties and to be overexpressed in multiple cancers including melanoma [22], where may represent a potential therapeutic target.